Mucosolvan 30mg Sanofi tablets dilute phlegm in bronchitis (2 blisters x 10 tablets)

Dosage form Box of 2 blisters x 10 tablets
Specifications Ambroxol

Ingredient

Composition information	Content
Ambroxol	30mg

Uses

indications

Mucosolvan 30 drugs are indicated in the following cases: The treatment of phlegm in acute and chronic bronchial diseases is related to abnormal mucus secretion and impaired mucus transport.

Pharmacological

Clinically clinically ambroxol hydrochlorid, the active ingredient of Mucosolvan, has been shown to increase the excretion of the respiratory tract. It increases the production of surfaces in the lungs (surfactant) and stimulates the activity of the velvet.

These activities improve the flow and transportation of mucus (purifying the mucus of velvet). The improvement of the mucus's mucus is observed in clinical pharmacological studies. The increase in the secretion and the effect of clearing the mucus of velvet mucus facilitates the sputum and soothes cough.

The local anesthetic effect is observed on the rabbit eye model that can be explained by sodium channel blockers. This is seen on in vitro, ambroxol hydrochlorid nerve sodium channel blockers; This cohesion can recover and depend on the concentration.

On In vitro, Ambroxol Hydrochlorid significantly reduces the release of cytokin from blood and from single and multi -core cells linked to tissue.

There has been a significant decrease in pain and throat redness in clinical studies in sore throat.

These pharmacological properties are related to observations in clinical effects of ambroxol hydrochlorid when treating symptoms of the upper respiratory tract, giving rapid pain relief results and uncomfortable discomfort related to ear - nose - trachea pain in the form of aerosol.

After using ambroxol hydrochlorid antibiotic concentration (amoxicillin, cefuroxim, erythromycin) in bronchial fluid - lungs and sputum increased.

Dynamic pharmacokinetics

Ambroxol absorb fast after oral, fast diffuse from blood to tissue with the highest drug concentration in the lungs. Birth is about 70%. The maximum concentration in plasma is achieved within 0.5 - 3 hours after taking the drug.

With the dose of treatment, the drug binds to plasma protein approximately 90%. Half life in plasma from 7 - 12 hours. Ambroxol is metabolized mainly in the liver. The drug excreted through the kidney is about 83%.

Before taking Mucosolvan 30mg Sanofi tablets dilute phlegm in bronchitis (2 blisters x 10 tablets)

How to use

oral medication. You can drink mucosolvan with or without food. Should take medicine with water.

Dosage

Adults: 1 tablet x 3 times daily.

The treatment effect can be increased by taking 2 tablets, 2 times daily. Should take medicine with water.

30 mg Mucosolvan tablets are used for adults and children over 12 years old.

Children from 6 to 12 years of age should use half a tablet, 2-3 times daily.

30 mg mucosolvan tablets should not be used for children under 6 years old.

In acute respiratory indications, see if the symptoms do not improve or worsen during treatment.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose? Based on the overdose reporting report and/or due to errors, the overdose symptoms are similar to the known side effects of Mucosolvan at the recommended dose and may need symptom treatment.

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not drink twice as prescribed.

Side Effects

When using Mucosolvan 30, you may experience unwanted effects (ADR).

Disorders of immune system, skin and subcutaneous tissue: Anaphylaxis reactions including anaphylaxis, angioedema, rash, urticaria, itching and other hypersensitivity reactions.

Disorders of the digestive system: Nausea, vomiting, diarrhea, indigestion and abdominal pain.

Notify the doctor with unwanted effects when taking the drug.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Mucosolvan 30 Drugs Contraindicated in the following cases:

Patients who have been sensitive to Ambroxol Hydrochlorid or other ingredients of the drug.

Rare genetic disease can be corresponding to one of the excipients of the drug.

Be cautious when using

very few reports of severe skin damage such as Stevens-Johnson syndrome and poisoned epidermal necrosis (Ten: Toxic Epidermal Necrolysis) related to the use of sputum drugs such as Ambroxol Hydrochlorid and are mainly explained by the severity of the severe level of infected pathology and/or medication.

Moreover in the early stage of Stevens-Johnson or Ten's syndrome, the patient may first show signs such as non-specific influenza such as fever, human pain, rhinitis, cough and sore throat. Symptoms such as uncompleted flu can lead to improper treatment of symptoms by cough and colds.

Therefore, if the skin damage or mucosa appears, be cautious by seeing a doctor immediately and should stop treating with ambroxol hydrochlorid.

If there is signs of impaired renal function, you should only use mucosolvan after consulting your doctor.

A tablet containing 171mg lactose corresponds to 684mg lactose for maximum daily recommendations (120mg). Patients with rare genetic diseases are galactose intolerance, Lapp Lactase deficiency or no absorption of glucose - Galactose should not use this drug.

The ability to drive and operate machinery

There is no evidence from after -sales data on the effect of the drug on the ability to drive and operate machinery. The research has not yet been conducted to affect the ability to drive and operate machinery.

Pregnancy

Ambroxol hydrochlorid through fetus fence. Subclinical studies do not show direct or indirect effects on pregnancy, embryo/fetal development, childbirth or child development.

Deeply clinical experience after 28 weeks of pregnancy shows no evidence of harmful effects for the fetus. However, be careful when using drugs for pregnant women. Especially in the first three months of pregnancy, it is recommended not to use Mucosolvan.

breastfeeding period

ambroxol hydrochlorid is secreted into breast milk. It is not recommended to use Mucosolvan for breastfeeding women although there is no adverse effects in breastfeeding children.

Drug interaction

has not seen an unfavorable interaction report with other drugs clinically.

Storage

In a dry place, avoid light, temperature below 30 ° C.

Expiry date: 36 months from the date of production.

Do not use overdue drugs indicated on the packaging.

Manufacturer: Delpharm Reims Pharmaceutical Company.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.